scispace - formally typeset
Journal ArticleDOI

Successful Treatment of Acromegaly: Metabolic and Clinical Studies in 145 Patients

TLDR
Using high-energy protons, and later the 910-MeV alpha-particle beam from a cyclotron to treat patients with acromegaly has achieved relief of symptoms and signs and a return to normal of elevated growthhormone levels and other metabolic levels.
Abstract
The successful treatment of acromegaly, a disorder related to hyperfunction of the pituitary gland and first described in 1886 by Marie, has long been sought. The relative insensitivity of the pituitary gland to externally delivered radiation is well known, and the endresults of treatment with conventional radiation have been relatively unsatisfactory—long periods of relief of signs and symptoms have not often been achieved and life expectancy has not been good. Surgical hypophysectomy, pituitary implants using gold-198 or yttrium-90, and cryohypophysectomy have recently been used with considerable success. Thirteen yr ago, after more than 20 yr of radiobiologic research with heavy particles, we started using high-energy protons, and later the 910-MeV alpha-particle beam from a cyclotron to treat patients with acromegaly.1 One hundred twenty patients have been treated, and we have achieved relief of symptoms and signs and a return to normal of elevated growthhormone levels and other metabolic abn...

read more

Citations
More filters
Journal ArticleDOI

Epidemiology of acromegaly in the newcastle region

TL;DR: A survey of the population in the area served by the former Newcastle Regional Hospital Board has been conducted to detect cases of acromegaly alive after 1 January 1960 and diagnosed before 31 December 1971, finding that in male acromegalics there was a significant increase in the risk of death from cardiovascular, cerebrovascular, respiratory and malignant diseases but in females from cerebroVascular disease only.
Journal ArticleDOI

Instrumentation for Treatment of Cancer Using Proton and Light-Ion Beams

TL;DR: This article reviews the beam modifying devices and associated dosimetric equipment developed specifically for controlling and monitoring the clinical beams.
Journal ArticleDOI

Epidemiology of acromegaly

TL;DR: There is an ongoing excess of patients with chronic complications of acromegaly leading to increased morbidity and mortality from the disorder, with observed-to-expected mortality ratios ranging from 1.6-3.3 and only approaching unity in those with growth hormone levels < 2.5 ug/L following treatment.
Journal ArticleDOI

Transsphenoidal microsurgical removal of 250 pituitary adenomas

TL;DR: The results are provided in summary form with emphasis on the favorable outcome following removal of microadenomas, and the complications observed after operation are presented.
Journal ArticleDOI

Drugs Five Years Later: Bromocriptine

TL;DR: Withdrawal of bromocriptine therapy is associated in most patients with reversal of its beneficial effects--return of hyperprolactinemia, return of excess growth hormone secretion, and exacerbation of Parkinson's disease.
Related Papers (5)